Figures & data
Figure 1 Fenretinide increased the expression of PPARγ in RAW264.3 macrophages.
Abbreviations: FEN, fenretinide; LPS, lipopolysaccharide; PPARγ, peroxisome proliferator-activated receptor gamma; SEM, standard error of the mean; GW, GW9662.
![Figure 1 Fenretinide increased the expression of PPARγ in RAW264.3 macrophages.](/cms/asset/28ba3c19-34f9-40ed-b62b-3b7d170b8809/dddt_a_12173073_f0001_b.jpg)
Figure 2 Fenretinide inhibited LPS-induced inflammatory mediators through PPARγ pathway.
![Figure 2 Fenretinide inhibited LPS-induced inflammatory mediators through PPARγ pathway.](/cms/asset/787ee8cb-87f2-43c3-a2c4-9242c5761d70/dddt_a_12173073_f0002_b.jpg)
Figure 3 Fenretinide inhibited LPS-induced iNOS expression PPARγ pathway.
Abbreviations: FEN, fenretinide; iNOS, inducible nitric oxide synthase; LPS, lipopolysaccharide; PPARγ, peroxisome proliferator-activated receptor gamma; SEM, standard error of the mean; GW, GW9662.
![Figure 3 Fenretinide inhibited LPS-induced iNOS expression PPARγ pathway.](/cms/asset/5a222d5a-a504-4237-b3e4-9f85e874f7aa/dddt_a_12173073_f0003_b.jpg)
Figure 4 Fenretinide inhibited LPS-induced NO production through PPARγ pathway.
Abbreviations: FEN, fenretinide; LPS, lipopolysaccharide; NO, nitrogen oxide; PPARγ, peroxisome proliferator-activated receptor gamma; SEM, standard error of the mean; GW, GW9662.
![Figure 4 Fenretinide inhibited LPS-induced NO production through PPARγ pathway.](/cms/asset/4aa9bd9c-48f2-4771-bca8-b5727cde6422/dddt_a_12173073_f0004_b.jpg)
Figure 5 Fenretinide controlled hypertension in SHR.
Abbreviations: BP, blood pressure; FEN, fenretinide; PPARγ, peroxisome proliferator-activated receptor gamma; SHR, spontaneously hypertensive rats; WKY, Wistar-Kyoto rats.
![Figure 5 Fenretinide controlled hypertension in SHR.](/cms/asset/75e76cec-b5f4-4a0f-a792-dfc5216ab42e/dddt_a_12173073_f0005_b.jpg)